REMINDER! Join DBHDS and OMNI for a SOR Community Forum: Understanding and Sharing Data on Tue 4/19 at 11am ET

The OMNI and DBHDS Teams invite you to join in our second CSB/Agency Treatment Community Forum, and our first of 2022. Per popular request, we will provide the opportunity for a facilitated discussion on understanding and sharing your data.

The Forum is Tuesday, April 19th from 11am-noon ET. Please click here to register for the Forum if you have not yet done so.

• First, DBHDS will provide some important updates for all on SOR III and highlight the importance of GPRA.

• Then, OMNI will provide a very quick refresher on the various reports and data sets we produce for DBHDS and for your agency. These include data from the GPRA and your quarterly survey responses. We'll also briefly review the VASIS (Virginia Social Indicator Study) Dashboard.

• OMNI will provide some tips on sharing your data, too. Overall, this is an informal forum during which all can hear from each other about how to use and share data to tell a story. We'll learn from each other, ask questions, and share existing best practices.

• Why is this so important? One reason: Sustainability! You can repurpose data that you already have in grant applications and more.

• We will also spotlight two agencies who successfully use reports or data to inform their teams, community, funders, and stakeholders.

Questions? Reach out to us at SORSupport@omni.org. See you in the Forum!

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.